BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8161344)

  • 1. Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.
    Walker D; Flinois JP; Monkman SC; Beloc C; Boddy AV; Cholerton S; Daly AK; Lind MJ; Pearson AD; Beaune PH
    Biochem Pharmacol; 1994 Mar; 47(7):1157-63. PubMed ID: 8161344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide.
    Huang Z; Roy P; Waxman DJ
    Biochem Pharmacol; 2000 Apr; 59(8):961-72. PubMed ID: 10692561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide.
    May-Manke A; Kroemer H; Hempel G; Bohnenstengel F; Hohenlöchter B; Blaschke G; Boos J
    Cancer Chemother Pharmacol; 1999; 44(4):327-34. PubMed ID: 10447581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
    Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
    Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation.
    McCune JS; Risler LJ; Phillips BR; Thummel KE; Blough D; Shen DD
    Drug Metab Dispos; 2005 Jul; 33(7):1074-81. PubMed ID: 15821045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer.
    Roy P; Tretyakov O; Wright J; Waxman DJ
    Drug Metab Dispos; 1999 Nov; 27(11):1309-18. PubMed ID: 10534317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.
    Granvil CP; Madan A; Sharkawi M; Parkinson A; Wainer IW
    Drug Metab Dispos; 1999 Apr; 27(4):533-41. PubMed ID: 10101149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide.
    Preiss R; Schmidt R; Baumann F; Hanschmann H; Hauss J; Geissler F; Pahlig H; Ratzewiss B
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):385-92. PubMed ID: 12136253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.
    Koyama N; Sasabe H; Miyamoto G
    Xenobiotica; 2002 Jul; 32(7):573-86. PubMed ID: 12162853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender difference in ifosfamide metabolism by human liver microsomes.
    Schmidt R; Baumann F; Hanschmann H; Geissler F; Preiss R
    Eur J Drug Metab Pharmacokinet; 2001; 26(3):193-200. PubMed ID: 11695720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.
    Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P
    Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
    Calinski DM; Zhang H; Ludeman S; Dolan ME; Hollenberg PF
    Drug Metab Dispos; 2015 Jul; 43(7):1084-90. PubMed ID: 25934575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.
    Ufer M; Svensson JO; Krausz KW; Gelboin HV; Rane A; Tybring G
    Eur J Clin Pharmacol; 2004 May; 60(3):173-82. PubMed ID: 15054565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes.
    Jang GR; Wrighton SA; Benet LZ
    Biochem Pharmacol; 1996 Sep; 52(5):753-61. PubMed ID: 8765473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.